Alanine

Alanine

SCHEMBL1421340

C[C@@H](C(=O)O)N1C(=O)CCC1=O.C[C@H](N)C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
SLC1A2 P43004 2/20 0.44
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
ALDH1A1 P00352 2/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 2/20 0.35
GAA P10253 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
SLC7A5 Q01650 2/20 0.33
ACE P12821 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57078 0.92 KMT2A (0.53) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL1564214 0.92 KMT2A (0.53) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
Ethylene Glycol SCHEMBL3521351 0.88 SLC1A2 (0.47) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL28121172 0.84 KMT2A (0.47) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
Phenylalanine SCHEMBL9392749 0.81 SLC7A5 (0.58) SLC1A2ALDH1A1PKMSLC7A5
Proline SCHEMBL16432404 0.80 MEN1 (0.34) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL10609538 0.79 KMT2A (0.53) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL9182487 0.77 KMT2A (0.49) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL18020563 0.74 SLC1A2 (0.45) KMT2AMEN1SLC1A2CSNK2A2CSNK2B
SCHEMBL542300 0.71 RAB9A (0.41) KMT2AMEN1SLC1A2CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297315-A2 COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES Danisco US Inc. (US) 2011-03-23 EP disclosed
WO-2009149145-A2 COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES DANISCO US INC., GENENCOR DIVISION (US) 2009-12-10 WO disclosed
EP-1807108-A2 METHODS FOR THE TREATMENT AND PREVENTION OF DISEASES OF BIOLOGICAL CONDUITS Proteon Therapeutics, Inc. (US) 2007-07-18 EP disclosed
WO-2006036804-A2 METHODS FOR THE TREATMENT AND PREVENTION OF DISEASES OF BIOLOGICAL CONDUITS PROTEON THERAPEUTICS, INC. (US) 2006-04-06 WO disclosed